<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28317866</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Mar</Month><Day>20</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents.</ArticleTitle><Pagination><StartPage>44701</StartPage><MedlinePgn>44701</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">44701</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep44701</ELocationID><Abstract><AbstractText>Cyclooxygenase-2 (COX-2) is one of the important mediators of inflammation in response to viral infection, and it contributes to viral replication, for example, cytomegalovirus or hepatitis C virus replication. The role of COX-2 in dengue virus (DENV) replication remains unclear. In the present study, we observed an increased level of COX-2 in patients with dengue fever compared with healthy donors. Consistent with the clinical data, an elevated level of COX-2 expression was also observed in DENV-infected ICR suckling mice. Using cell-based experiments, we revealed that DENV-2 infection significantly induced COX-2 expression and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) production in human hepatoma Huh-7 cells. The exogenous expression of COX-2 or PGE<sub>2</sub> treatment dose-dependently enhanced DENV-2 replication. In contrast, COX-2 gene silencing and catalytic inhibition sufficiently suppressed DENV-2 replication. In an ICR suckling mouse model, we identified that the COX-2 inhibitor NS398 protected mice from succumbing to life-threatening DENV-2 infection. By using COX-2 promoter-based analysis and specific inhibitors against signaling molecules, we identified that NF-&#x3ba;B and MAPK/JNK are critical factors for DENV-2-induced COX-2 expression and viral replication. Altogether, our results reveal that COX-2 is an important factor for DENV replication and can serve as a potential target for developing therapeutic agents against DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Kuang</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yu-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Chih-Chuang</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Marine Biotechnology and Resources, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Ching</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022762">CCAAT-Enhancer-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009578">Nitrobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>123653-11-2</RegistryNumber><NameOfSubstance UI="C080955">N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>K7Q1JQR04M</RegistryNumber><NameOfSubstance UI="D015232">Dinoprostone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000833" MajorTopicYN="N">Animals, Suckling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055162" MajorTopicYN="N">Biocatalysis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022762" MajorTopicYN="N">CCAAT-Enhancer-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015232" MajorTopicYN="N">Dinoprostone</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="Y">Molecular Targeted Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009578" MajorTopicYN="N">Nitrobenzenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28317866</ArticleId><ArticleId IdType="pmc">PMC5357798</ArticleId><ArticleId IdType="doi">10.1038/srep44701</ArticleId><ArticleId IdType="pii">srep44701</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray N. E., Quam M. B. &amp; Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clinical epidemiology 5, 299&#x2013;309, doi: 10.2147/CLEP.S34440 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S34440</ArticleId><ArticleId IdType="pmc">PMC3753061</ArticleId><ArticleId IdType="pubmed">23990732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontaine K. A., Sanchez E. L., Camarda R. &amp; Lagunoff M. Dengue virus induces and requires glycolysis for optimal replication. Journal of virology 89, 2358&#x2013;2366, doi: 10.1128/JVI.02309-14 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02309-14</ArticleId><ArticleId IdType="pmc">PMC4338897</ArticleId><ArticleId IdType="pubmed">25505078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D. J. Dengue and dengue hemorrhagic fever. Clinical microbiology reviews 11, 480&#x2013;496 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S. W. et al.. Current progress in dengue vaccines. Journal of biomedical science 20, 37, doi: 10.1186/1423-0127-20-37 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-37</ArticleId><ArticleId IdType="pmc">PMC3686670</ArticleId><ArticleId IdType="pubmed">23758699</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard L. G., Filomatori C. V. &amp; Gamarnik A. V. Functional RNA elements in the dengue virus genome. Viruses 3, 1739&#x2013;1756, doi: 10.3390/v3091739 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3091739</ArticleId><ArticleId IdType="pmc">PMC3187688</ArticleId><ArticleId IdType="pubmed">21994804</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi R. F., Zhang L. &amp; Chi C. W. Biological characteristics of dengue virus and potential targets for drug design. Acta biochimica et biophysica Sinica 40, 91&#x2013;101 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18235970</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisinger A. L., Prescott S. M., Jones D. A. &amp; Stafforini D. M. The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins &amp; other lipid mediators 82, 147&#x2013;154, doi: 10.1016/j.prostaglandins.2006.05.026 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2006.05.026</ArticleId><ArticleId IdType="pubmed">17164142</ArticleId></ArticleIdList></Reference><Reference><Citation>Noguchi K. et al.. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts. Journal of dental research 79, 1955&#x2013;1961 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11201045</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo O. et al.. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3, 53&#x2013;61, doi: 10.1038/sj/neo/7900127 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj/neo/7900127</ArticleId><ArticleId IdType="pmc">PMC1505025</ArticleId><ArticleId IdType="pubmed">11326316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y. T. et al.. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PloS one 8, e54466, doi: 10.1371/journal.pone.0054466 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054466</ArticleId><ArticleId IdType="pmc">PMC3554764</ArticleId><ArticleId IdType="pubmed">23365670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W. H., Hsieh H. L. &amp; Yang C. M. Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappaB, and AP-1 in SK-N-SH cells: Role of PGE(2) in viral replication. Cellular signalling 22, 234&#x2013;246, doi: 10.1016/j.cellsig.2009.09.018 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.09.018</ArticleId><ArticleId IdType="pubmed">19800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Cong J. P., Yu D., Bresnahan W. A. &amp; Shenk T. E. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proceedings of the National Academy of Sciences of the United States of America 99, 3932&#x2013;3937, doi: 10.1073/pnas.052713799 (2002).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.052713799</ArticleId><ArticleId IdType="pmc">PMC122626</ArticleId><ArticleId IdType="pubmed">11867761</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X. et al.. Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter. Virology journal 8, 118, doi: 10.1186/1743-422X-8-118 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-118</ArticleId><ArticleId IdType="pmc">PMC3066118</ArticleId><ArticleId IdType="pubmed">21401943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhardt B. M., Varnell E. D. &amp; Kaufman H. E. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics 21, 114&#x2013;120, doi: 10.1089/jop.2005.21.114 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jop.2005.21.114</ArticleId><ArticleId IdType="pubmed">15857277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. M., Gai W. W., Cheung T. K. &amp; Peiris J. S. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro. Antiviral research 91, 330&#x2013;334, doi: 10.1016/j.antiviral.2011.07.011 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.07.011</ArticleId><ArticleId IdType="pubmed">21798291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. J., Raung S. L., Kuo M. D. &amp; Wang Y. M. Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. The Journal of general virology 83, 1897&#x2013;1905, doi: 10.1099/0022-1317-83-8-1897 (2002).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-8-1897</ArticleId><ArticleId IdType="pubmed">12124453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. et al.. Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE(2) expression. Virology journal 12, 35, doi: 10.1186/s12985-015-0264-x (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0264-x</ArticleId><ArticleId IdType="pmc">PMC4351682</ArticleId><ArticleId IdType="pubmed">25890183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C. K. et al.. Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-kappaB- and MAPK-ERK1/2-mediated COX-2 expression. British journal of pharmacology, doi: 10.1111/bph.13233 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13233</ArticleId><ArticleId IdType="pmc">PMC4562509</ArticleId><ArticleId IdType="pubmed">26102077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W. L., Ho L. J., Chang D. M., Chen C. H. &amp; Lai J. H. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. European journal of immunology 39, 3413&#x2013;3422, doi: 10.1002/eji.200939306 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200939306</ArticleId><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A. K., Sung S. H., Kim Y. C. &amp; Kim S. G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation. British journal of pharmacology 139, 11&#x2013;20, doi: 10.1038/sj.bjp.0705231 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0705231</ArticleId><ArticleId IdType="pmc">PMC1573829</ArticleId><ArticleId IdType="pubmed">12746218</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer S. A. &amp; Corbett J. A. The role and regulation of COX-2 during viral infection. Viral immunology 16, 447&#x2013;460, doi: 10.1089/088282403771926283 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282403771926283</ArticleId><ArticleId IdType="pubmed">14733733</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou J. T. et al.. Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. European journal of pharmacology 589, 288&#x2013;298, doi: 10.1016/j.ejphar.2008.04.056 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2008.04.056</ArticleId><ArticleId IdType="pmc">PMC7094504</ArticleId><ArticleId IdType="pubmed">18565510</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W. H., Hsieh H. L., Lee I. T. &amp; Yang C. M. Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. Journal of cellular biochemistry 112, 559&#x2013;570, doi: 10.1002/jcb.22946 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22946</ArticleId><ArticleId IdType="pmc">PMC7166325</ArticleId><ArticleId IdType="pubmed">21268077</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselah T. &amp; Marcellin P. New direct-acting antivirals&#x2019; combination for the treatment of chronic hepatitis C. Liver international: official journal of the International Association for the Study of the Liver 31 Suppl 1, 68&#x2013;77, doi: 10.1111/j.1478-3231.2010.02411.x (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1478-3231.2010.02411.x</ArticleId><ArticleId IdType="pubmed">21205141</ArticleId></ArticleIdList></Reference><Reference><Citation>Naggie S. &amp; Sulkowski M. S. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology 142, 1324&#x2013;1334 e1323, doi: 10.1053/j.gastro.2012.02.012 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2012.02.012</ArticleId><ArticleId IdType="pmc">PMC3637982</ArticleId><ArticleId IdType="pubmed">22537439</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy S., Shackelton L. A. &amp; Holmes E. C. Rates of evolutionary change in viruses: patterns and determinants. Nature reviews. Genetics 9, 267&#x2013;276, doi: 10.1038/nrg2323 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2323</ArticleId><ArticleId IdType="pubmed">18319742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurain N. S., Thompson K. D., Holmes E. W. &amp; Read G. S. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. Journal of virology 66, 7146&#x2013;7152 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240402</ArticleId><ArticleId IdType="pubmed">1331515</ArticleId></ArticleIdList></Reference><Reference><Citation>Prussia A., Thepchatri P., Snyder J. P. &amp; Plemper R. K. Systematic approaches towards the development of host-directed antiviral therapeutics. International journal of molecular sciences 12, 4027&#x2013;4052, doi: 10.3390/ijms12064027 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms12064027</ArticleId><ArticleId IdType="pmc">PMC3131607</ArticleId><ArticleId IdType="pubmed">21747723</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink J. et al.. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS neglected tropical diseases 1, e86, doi: 10.1371/journal.pntd.0000086 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000086</ArticleId><ArticleId IdType="pmc">PMC2100376</ArticleId><ArticleId IdType="pubmed">18060089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S. P. et al.. Ten years of dengue drug discovery: progress and prospects. Antiviral research 100, 500&#x2013;519, doi: 10.1016/j.antiviral.2013.09.013 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.09.013</ArticleId><ArticleId IdType="pubmed">24076358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang Y. C. et al.. Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection. Journal of the Formosan Medical Association&#x2009;=&#x2009;Taiwan yi zhi 112, 12&#x2013;17, doi: 10.1016/j.jfma.2012.10.013 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.10.013</ArticleId><ArticleId IdType="pubmed">23332424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Woda M., Ennis F. A. &amp; Libraty D. H. Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. The Journal of infectious diseases 200, 191&#x2013;201, doi: 10.1086/599795 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/599795</ArticleId><ArticleId IdType="pmc">PMC3881588</ArticleId><ArticleId IdType="pubmed">19530939</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho D. M. et al.. Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients. Journal of tropical medicine 2014, 901276, doi: 10.1155/2014/901276 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/901276</ArticleId><ArticleId IdType="pmc">PMC4279176</ArticleId><ArticleId IdType="pubmed">25580138</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Mestre M. T., Gendzekhadze K., Rivas-Vetencourt P. &amp; Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue antigens 64, 469&#x2013;472, doi: 10.1111/j.1399-0039.2004.00304.x (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2004.00304.x</ArticleId><ArticleId IdType="pubmed">15361124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. P., Hao X. Q., Zhang L. M. &amp; Tian Y. T. Enhanced cyclooxygenase-2 activity leads to intestinal dysmotility following hemorrhagic shock. Acta cirurgica brasileira/Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia 30, 838&#x2013;843, doi: 10.1590/S0102-865020150120000008 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0102-865020150120000008</ArticleId><ArticleId IdType="pubmed">26735056</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A. A. et al.. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 48, 339&#x2013;346 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1760142</ArticleId><ArticleId IdType="pubmed">11171823</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S. S. et al.. Propofol Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats. Journal of molecular neuroscience: MN 57, 538&#x2013;545, doi: 10.1007/s12031-015-0634-2 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0634-2</ArticleId><ArticleId IdType="pubmed">26342279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S. H. et al.. Diallyl Disulfide Prevents Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats through the Inhibition of Oxidative Damage, MAPKs, and NF-kappaB Pathways. Biomolecules &amp; therapeutics 23, 180&#x2013;188, doi: 10.4062/biomolther.2014.126 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2014.126</ArticleId><ArticleId IdType="pmc">PMC4354320</ArticleId><ArticleId IdType="pubmed">25767687</ArticleId></ArticleIdList></Reference><Reference><Citation>W.H.O. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition (2009).</Citation></Reference><Reference><Citation>Lee J. C. et al.. Characterization of the activity of 2&#x2032;-C-methylcytidine against dengue virus replication. Antiviral research 116, 1&#x2013;9, doi: 10.1016/j.antiviral.2015.01.002 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.01.002</ArticleId><ArticleId IdType="pubmed">25614455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y. C. et al.. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Archives of virology 157, 681&#x2013;688, doi: 10.1007/s00705-012-1224-z (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1224-z</ArticleId><ArticleId IdType="pubmed">22249364</ArticleId></ArticleIdList></Reference><Reference><Citation>Speir E., Yu Z. X., Ferrans V. J., Huang E. S. &amp; Epstein S. E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 83, 210&#x2013;216 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9686761</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan K., Singh S., Burke T. R. Jr., Grunberger D. &amp; Aggarwal B. B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America 93, 9090&#x2013;9095 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC38600</ArticleId><ArticleId IdType="pubmed">8799159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K. J. et al.. Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation. PloS one 8, e57704, doi: 10.1371/journal.pone.0057704 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057704</ArticleId><ArticleId IdType="pmc">PMC3585194</ArticleId><ArticleId IdType="pubmed">23469054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. C. et al.. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral research 89, 35&#x2013;42, doi: 10.1016/j.antiviral.2010.11.003 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.11.003</ArticleId><ArticleId IdType="pubmed">21075144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. R. et al.. Dengue virus infection induces autophagy: an in vivo study. Journal of biomedical science 20, 65, doi: 10.1186/1423-0127-20-65 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-65</ArticleId><ArticleId IdType="pmc">PMC3848819</ArticleId><ArticleId IdType="pubmed">24011333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. R. et al.. Suckling mice were used to detect infectious dengue-2 viruses by intracerebral injection of the full-length RNA transcript. Intervirology 48, 161&#x2013;166, doi: 10.1159/000081744 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000081744</ArticleId><ArticleId IdType="pubmed">15812190</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>